Fluvoxamine maleate is a selective SR (serotonin reputake) inhibitor. Fluvoxamine is described to bind the human 5-HT transporter protein with high affinity (Ki = 1.6 nM) while demonstrating very low affinity at the norepinephrine transporter (Ki = 2,950 nM). Fluvoxamine maleate is a Sigma Receptor agonist.
Fluvoxamine Maleate
| Description | |
|---|---|
| (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine | |
| 61718-82-9 | |
| C19H25F3N2O6 | |
| FLUVOXAMINE MALEATE;(E)-5-METHOXY-1-[4-(TRIFLUOROMETHYL)PHENYL]-1-PENTANONE-O-(2-AMINOETHYL)OXIME MALEATE;1-pentanone,5-methoxy-1-(4-(trifluoromethyl)phenyl)-,o-(2-aminoethyl)oxime,(;5-methoxy-4’-trifluoromethylvalerophenone(e)-o-2-aminoethyloximemonomaleate;du23000;faverin50;(E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]-O-(2-aminoethyl)oxime-1-pentanone;MK-264, DI-23000, Dumirox, Flaverrin, Fevarin, Floxyfral, Luvox, Maveral, (E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone, Maleate, | |
| Anxiety disorder | |
Copyright © 2014. All Rights Reserved at Jai Radhe Sales.
Powered by: Adit Microsys
